Market Overview

FDA Posts Briefing Documents for J&J's Canagliflozin

Related JNJ
New Active ETF for All Risk Environments
3 Companies Investing In Stem Cell Research
U.S., U.K. ISIS Response Differ Widely (Fox Business)

View briefing document.

Posted-In: News

 

Related Articles (JNJ)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters